JOURNAL OF PINEAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-09-22 ms7000001623486299 来自北京

想咨询一下这个期刊第一个决定一般多久哇

53 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-08-27 fanfan8231 来自重庆

审稿速度:1.0
偏重的研究方向：脑病
经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？

68 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-09-01 1811e984f8m 来自安徽省

偏重的研究方向：分子生物学
经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………

68 0

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-12-14 769023184 来自湖北省

under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？

194 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-08-05 白.

请问WB的原始数据要不要未裁剪的膜

224 0

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-07-21 ms2000001196837930

2021
JOURNAL IMPACT FACTOR：12.081
JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493

215 0

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-07-21 ms2000001196837930

审稿速度:6.0 | 投稿命中率:25.0
经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。
换主编后，目前杂志自引率在6%。
说杂志水的，自己先能去发一篇吧！

231 0

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-03-10 小小心

投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历

276 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 MS54455111222

上传文章有什么要求？

226 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2227039, encodeId=87b6222e0399a, content=想咨询一下这个期刊第一个决定一般多久哇 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c0c8360200, createdName=ms7000001623486299, createdTime=Sun Sep 22 15:03:39 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2222670, encodeId=6d6e22226e0c0, content=审稿速度:1.0 偏重的研究方向：脑病 经验分享：我的文章投过去编辑让添加通讯作者邮箱和作者贡献耽误了三天，然后周一正式投到编辑部，周三收到主编邮件让修改，说样本量小了和统计结果不严谨，可能还要补实验，请问补实验后还需要经过外审吗，还是主编直接就接收了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13c5867, createdName=fanfan8231, createdTime=Tue Aug 27 15:29:58 CST 2024, time=2024-08-27, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2223470, encodeId=aaed22234e0e5, content=偏重的研究方向：分子生物学 经验分享：即影响因子3.78。明年影响因子大概率6分左右，离高光时刻渐行渐远。投这个杂志就跟投资A股一样，一言难尽………, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Sep 01 08:38:02 CST 2024, time=2024-09-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2106060, encodeId=e37821060608e, content=under review 8天了，不知道是不是外审了，有大神能给个投稿过程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJSGtKFrlXheIM9YR1OnEsickgPH4pJIdz87zLDlmSqeia3DOZl3EjRk941VFh6zVPTSzJOicC5aDhBg/132, createdBy=12d34674271, createdName=769023184, createdTime=Wed Dec 14 20:21:23 CST 2022, time=2022-12-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1236826, encodeId=cea4123682647, content=请问WB的原始数据要不要未裁剪的膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/05/e5d4ed003059edd298ab8b1b2b96b230.jpg, createdBy=36cd2283376, createdName=白., createdTime=Fri Aug 05 20:02:32 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233901, encodeId=abc0123390141, content=2021 JOURNAL IMPACT FACTOR：12.081 JOURNAL IMPACT FACTOR WITHOUT SELF CITATIONS：11.493, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:29:13 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233897, encodeId=7535123389e87, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：对于我们这些非关系户，能中，就是运气+实力。录用论文实验数据量大，属于博士学位的大部分内容。 换主编后，目前杂志自引率在6%。 说杂志水的，自己先能去发一篇吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bf015495976, createdName=ms2000001196837930, createdTime=Thu Jul 21 20:15:44 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947247, encodeId=9a3194e247f7, content=投稿第二天变成under review，我看wiley杂志不送审也会显示under review状态，求大神分享投稿经历, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ae22029817, createdName=小小心, createdTime=Wed Mar 10 21:56:24 CST 2021, time=2021-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093981, encodeId=3c96109398149, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093982, encodeId=6642109398272, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 MS68862005

如何判断两种药物之间是协同作用还是相加作用？

0 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务